ZNTL Financials
Zentalis Pharmaceuticals Llc - Financial statements & key metrics
Stock Price
$3.71
Market Cap
$257.69M
P/E Ratio
-1.6
EPS
$-2.33
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$67.42M
Gross Profit
-
Operating Income
-
Net Income
$-165.87M
EPS (Diluted)
$-2.33
Balance Sheet Highlights
Total Assets
$430.34M
Total Liabilities
$93.15M
Shareholders Equity
-
Cash & Equivalents
$33.90M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-170.86M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Net Margin
-246.0%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is ZNTL revenue?
ZNTL's most recent quarterly revenue was $67.42M. Annual revenue can be calculated by summing the four most recent quarters.
Is ZNTL profitable?
ZNTL reported a loss of $165.87M in the most recent quarter. The net profit margin is -246.0%.
What is ZNTL market cap?
ZNTL has a market capitalization of $257.69M, making it a small-cap stock.
Does ZNTL have debt?
View ZNTL's balance sheet for debt information.
What is ZNTL cash flow?
Cash flow data is available in the full financial statements.